IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Artia Global Partners LP

Q4 2023 Holdings

Filed 2024-02-14 | 31 holdings | $343.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Novo-Nordisk A S(NVO)ADR670100205$74.6M721,50721.7%
ELI Lilly & Co(LLY)COM532457108$54.0M92,59315.7%
Merck & Co Inc(MRK)COM58933Y105$35.9M329,20010.4%
Cytokinetics IncCallCALL23282W905$33.8M404,9009.8%
Cytokinetics IncPutPUT23282W955$33.4M400,5009.7%
ELI Lilly & CoPutPUT532457958$23.3M40,0006.8%
Abbvie Inc(ABBV)COM00287Y109$14.1M90,8214.1%
Argenx SE(ARGX)SPONSORED ADR04016X101$13.0M34,2383.8%
Astrazeneca PLC(AZN)SPONSORED ADR046353108$12.8M190,7523.7%
Viking Therapeutics Inc(VKTX)COM92686J106$7.1M383,5802.1%
Axsome Therapeutics Inc(AXSM)COM05464T104$7.0M87,8482.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$5.9M45,0001.7%
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$3.0M41,6000.9%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$2.8M28,8850.8%
Cytokinetics Inc(CYTK)COM NEW23282W605$2.7M32,1130.8%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$2.6M130,7900.8%
Protagonist Therapeutics Inc(PTGX)COM74366E102$2.6M112,3400.7%
Vaxcyte Inc(PCVX)COM92243G108$2.4M38,5550.7%
Insmed Inc(INSM)COM PAR $.01457669307$2.3M74,9360.7%
Ocular Therapeutix Inc(OCUL)COM67576A100$2.0M440,0000.6%
Pliant Therapeutics Inc(PLRX)COM729139105$1.8M100,0000.5%
Charles RIV Labs Intl Inc(CRL)COM159864107$1.6M6,9050.5%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$1.2M50,0000.3%
Waters Corp(WAT)COM941848103$936.7K2,8450.3%
Immunovant Inc(IMVT)COM45258J102$901.5K21,3970.3%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$488.0K19,6380.1%
Structure Therapeutics IncPutPUT86366E956$407.6K10,0000.1%
Biomea Fusion Inc(BMEA)COM09077A106$369.6K25,4520.1%
Apogee Therapeutics Inc(APGE)COM03770N101$290.0K10,3810.1%
Gritstone BIO Inc(2JQ)COM39868T105$194.1K95,1700.1%
Tyra Biosciences Inc(TYRA)COM90240B106$142.0K10,2530.0%